All articles tagged with #nih grants
The Trump administration's move to cut NIH grants related to diversity, equity, and inclusion is being reconsidered after a legal settlement, allowing the agency to review previously frozen or denied applications without the influence of political directives, though future projects may face increased scrutiny.
Dana-Farber Cancer Institute agreed to pay $15 million to settle allegations of scientific research fraud involving falsified data and images in publications supported by NIH grants, with misconduct spanning from 2014 to 2024, and the institute cooperated with investigations.
The US Supreme Court has allowed the Trump administration to proceed with nearly $2 billion in NIH research grant cuts, ruling that lawsuits challenging the cuts should be reviewed by a contract-specialized court, but upheld the lower court's decision that the guidelines used for the cuts are illegal, effectively limiting researchers' ability to challenge such funding reductions in the future.
The US Supreme Court allowed the Trump administration to temporarily halt millions of dollars in NIH research grants linked to policies on diversity, equity, and inclusion, while leaving some legal questions unresolved and indicating that affected parties might pursue further legal action.
The US Supreme Court allowed the Trump administration to proceed with significant cuts to NIH grants related to diversity, equity, and inclusion, overturning a lower court ruling that found these cuts unlawful, amid ongoing legal challenges from researchers and states.
The Supreme Court has approved nearly $800 million in cuts to NIH grants, enabling the Trump administration to reduce funding for health research concerning minority, gay, and transgender communities amid ongoing legal disputes.
The Supreme Court allowed the Trump administration to withhold NIH grants linked to diversity, equity, and inclusion initiatives, citing executive orders targeting such programs and biological sex policies, while legal disputes over the grants continue.
The Supreme Court temporarily allowed the NIH to halt nearly $800 million in research grants, overturning a lower court order, amid ongoing legal disputes over the administration's policy of terminating grants that do not align with its objectives, including those related to diversity, vaccine hesitancy, and COVID-19 research.
Harvard researchers face severe disruptions due to recent federal funding cuts, risking the termination of vital research projects across various fields, including disease studies, space exploration, and social health, with significant implications for scientific progress and public health.
A federal judge ruled that the Trump administration's cancellation of NIH grants was illegal, citing discrimination against racial, LGBTQ+, and diversity-related research, and ordered some grants to be reinstated, highlighting concerns over political interference in scientific research.
A federal judge in Massachusetts ruled that the Trump administration's cancellations of NIH research grants related to LGBTQ+ issues and diversity were 'void' and 'illegal,' ordering the grants to be reinstated, citing violations of federal law and discrimination. The decision challenges the administration's stance that such research was ideologically driven and not scientifically valid.
A federal judge in Boston ruled that the Trump administration's cancellation of over $1 billion in NIH diversity-related research grants was illegal and discriminatory against minorities and LGBTQ individuals, ordering the grants to be reinstated and criticizing the government for racial and social bias.
A federal judge ruled that the termination of hundreds of NIH research grants by the Trump administration is 'void and illegal,' providing a temporary victory for researchers affected by the funding cuts, which totaled approximately $1.8 billion or more.
The Trump administration has significantly cut and delayed nearly 2,500 medical research grants from the NIH, affecting a wide range of studies including those on cancer, Alzheimer's, and health disparities, which could have long-term impacts on U.S. scientific progress.